Direct-to-consumer advertising in New Zealand
New Zealand is one of only two OECD countries that allows direct-to-consumer advertising of prescription drugs. (The other is the United States).
Other SourceWatch Resources
On DTC in NZ
Other DTC Related Articles
- Drug industry
- Pharmaceutical Research and Manufacturers of America
- Direct-to-consumer advertising
- Direct-to-consumer advertising: Canada's Ban
- Direct-to-consumer advertising: CanWest's Bid to Overturn Canada's Ban
- Direct-to-consumer advertising in the United States
- Disease awareness campaigns
- P. Pratt, The results of a regulatory compliance survey of direct-to-consumer advertisements for medicines. Wellington: Ministry of Health (Medsafe); 2000.
- PHARMAC, "Fiscal Impact of Direct to Consumer Advertising (DTCA)", November 2002. (This document was released under the Official Information Act following a request by NZ Greens MP Sue Kedgeley. The notations in the margins of the document were from staff in Kedgeley's office not on the original.)
- Annette King, "Direct to Consumer Advertising", Media Statement, February 17, 2003.
- Annette King, "Mid-winter dialogue", Christchurch Medical School, Speech presented on 07 August 2003. (Towards the bottome she makes some comments about Cabinet deliberations on DTCA).
Medical Academics Articles
- Peter Mansfield, "Report on DTC pharmaceutical promotion for PHARMAC", Ministry of Health (2000). Direct to consumer advertising of prescription medicines in New Zealand: A discussion paper, November 2000.
- Les Toop and Dee Richards, "DTCA in New Zealand: the challenge of finding an acceptable balance", British Journal of General Practice, Volume 52, Number 477, 2002, page 341.
- Les Toop, "Report Calls For Ban on Advertising Prescription Drugs", University of Otago, Media Release, February 16, 2003.
- Les Toop, Dee Richards, Tony Dowell, Murray Tilyard, Tony Fraser, Bruce Arroll, "Direct to consumer advertising of prescription drugs in New Zealand: For health or for profit? Report to Minister of Health calling for a ban on DTCA", University of Otago, February 2003.
- Professor Donald Evans, "Preliminary inquiry into the Advertising Authority Complaint – Professors Dowell, Tilyard and Toop", University of Otago; February 3, 2003.
- Colmar Brunton Social Research Agency, "Consumer opinion: prescription medicines" (information prepared for Christchurch School of Medicine, New Zealand), University of Otago, February 2003.
- Les Toop and Dee Richards, "New Zealand deserves better. Direct-to-consumer advertising (DTCA) of prescription medicines in New Zealand: for health or for profit?", New Zealand Medical Journal, Journal of the New Zealand Medical Association, 22-August-2003, Vol 116 No 1180.
- Les Toop, Dee Richards, Tony Dowell, "The leadership role of general practice in public health: advocating a ban of direct-to-consumer advertising of prescription drugs in New Zealand. 'Possums in the headlights?'", British Journal of General Practice, Volume 53, Number 489, 2003, page 342-5.
- Les Toop and Dee Richards, "Physicians’ negative views of direct-to-consumer advertising (DTCA): the international evidence grows", New Zealand Medical Journal, Volume 117, Number 1195, 2004.
- Les Toop and D Mangin, "The impact of advertising prescription medicines directly to consumers in New Zealand: lessons for Australia", Australian Prescriber, Volume 29 Number 2, April 2006, page 30-2.
- Les Toop and Dee Mangin, "Direct to consumer advertising: Industry funded patient information and the slippery slope to New Zealand", British Medical Journal, Volume 335, October 6, 2007, pp.694-695 (Sub req'd).
Marketing Academics Articles and Presentations
- Sandra Coney, "Direct to Consumer advertising of prescription pharmaceuticals A consumer perspective from New Zealand", Journal of Public Policy and Marketing, Volume 21 Number 2, 2002, pages 213-223.
- Janet Hoek, "DTCA: A New Zealand Experience", Proceedings of an American Enterprise Institute Seminar Direct to Consumer Advertising of Prescription Drugs, Washington D.C., May 27, 2003.
- Janet Hoek and Philip Gendall, "Regulation of Prescription Medicines Advertising In the United States and New Zealand: A Consumer Perpsective", Department of Marketing, Massey University, Palmerston North, New Zealand, WAPOR Conference, Phoenix, Arizona, 11-13 May, 2004.
- Janet Hoek, Philip Gendall and P. Feetham, "Could less be more?: An analysis of direct to consumer advertising of prescription medicines", Marketing Bulletin, 2001.
- Janet Hoek and Philip Gendall, "Direct to consumer advertising of prescription medicines: Self-regulation or legislation?", Journal of Marketing Communications, Volume 8, Number 2, 2002, pages 71-85.
- Janet Hoek and Philip Gendall, DTC down under: An alternative perspective and regulatory framework, Journal of Public Policy and Marketing, Volume 18 Number 2, 2002, pages 202-212.
- Janet Hoek and Philip Gendall, "Direct to consumer advertising of prescription medicines: A consumer survey", Department of Marketing Research Report, April, 2003.
- Bob Burton, "Ban direct to consumer advertising, report recommends", British Medical Journal, March 2003.
- Zosia Kmietowicz, "New Zealand GPs call for end to direct to consumer advertising", British Medical Journal, June 2003.
- Barrie Saunders, "Direct-to-consumer advertising - where does the public interest lie", New Zealand Medical Journal, Volume no 116 No 1180, August 22, 2003.
- Bob Burton, "New Zealand moves to ban direct advertising of drugs", British Medical Journal, January 2004;
- "Direct to consumer advertisements to stop", British Medical Journal, January 2004.
- Bob Burton, "Drug industry to fight New Zealand's move to ban direct to consumer advertising", British Medical Journal, May 2004.
|This article is a stub. You can help by expanding it.|